Journal of Commercial Biotechnology
Journal of Commercial Biotechnology
Journal of Commercial Biotechnology
Submissions
Subscribe
Current
Archives
Search
About
About the Journal
Editorial Team
Privacy Statement
Contact
Register
Login
Register
Login
Current Issue
Vol 25 No 4 (2020)
Published December 11, 2020
Commentary
Arthur A Boni
What’s Coming Next in Transformative Innovation? Announcing “The Annual JCB Top 50 Organizations for Transformative Innovation in Biopharma, Med Tech and Digital Health”
https://doi.org/10.5912/jcb949
Requires Subscription or Fee
PDF
Peter Pitts
A Healthcare Pilgrim's Progress
https://doi.org/10.5912/jcb932
Requires Subscription or Fee
PDF
Articles
Arthur Boni, Dennis M. Gross
Emerging, Transformative Technologies: Promises and Business Model Challenges
https://doi.org/10.5912/jcb948
Requires Subscription or Fee
PDF
Arthur A Boni
An introductory perspective on emerging, transformative technologies in biopharma: promises, challenges and impediments
https://doi.org/10.5912/jcb950
Requires Subscription or Fee
PDF
Richard Murphey
A framework for comparing R&D productivity at big pharma companies vs. biotech startups
https://doi.org/10.5912/jcb951
Requires Subscription or Fee
PDF
Saul Kaplan
Personalized Medicine by Design
https://doi.org/10.5912/jcb952
Requires Subscription or Fee
PDF
Christopher Moehle, Jessica Gibson
Augmenting Healthcare with Human-Centered Technologies
https://doi.org/10.5912/jcb953
Requires Subscription or Fee
PDF
John Baldoni, Edmon Begoli, Dimitri Kusnezov, John MacWilliams
Solving Hard Problems with AI: Dramatically Accelerating Drug Discovery Through A Unique Public-Private Partnership
https://doi.org/10.5912/jcb954
Requires Subscription or Fee
PDF
Marc Watrous, PhD, Daniel S. Levine
Lessons from Sovaldi: Fueling Innovation While Ensuring Access
https://doi.org/10.5912/jcb942
Requires Subscription or Fee
PDF
From the Boardroom
Arthur A Boni
The “Art of Collaborations”: Understanding the Anatomy of Transformative Transactions in Biopharma
https://doi.org/10.5912/jcb955
Requires Subscription or Fee
PDF
Michael J. Kamdar , J. William Efcavitch
Commercializing the new frontier in DNA writing: Enzymatic synthesis
https://doi.org/10.5912/jcb956
Requires Subscription or Fee
PDF
Arthur A Boni
Challenges for Transformative Innovation in Emerging Digital Health Organizations: advocating service design to address the multifaceted healthcare ecosystem
https://doi.org/10.5912/jcb957
Requires Subscription or Fee
PDF
Amy Dow, Jennifer E. Michael , Lauren Sullivan
Legal and Compliance Considerations When Bringing Cellular Therapies to Market
https://doi.org/10.5912/jcb958
Requires Subscription or Fee
PDF
View All Issues
×
Username
*
Required
Password
*
Required
Forgot your password?
Keep me logged in
Login
No account?
Register here